Delivery Order SPE2DB24D1205-SPE2DB25FDAHY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12.7K to AmerisourceBergen Drug Corp for LONSURF 20 mg-8.19 mg tablets (60-count supply). This non-set-aside, firm fixed-price delivery order was awarded on July 24, 2025, with completion scheduled for August 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LONSURF is a prescription oncology medication used in cancer treatment, reflecting the company's role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $5,124.17 and firm fixed pricing. This delivery order, which is not set-aside, is scheduled for completion by August 28, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LONSURF (20 mg-8.19 mg tablets, 60-count packages) with a ceiling value of $10,173.33. This competitively awarded, non-set-aside contract is scheduled for completion by September 30, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $10,173.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LONSURF (trifluridine/tipiracil) 20 mg-8.19 mg tablets in quantities of 60 units. This delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), is scheduled for completion by September 30, 2025, with performance at the vendor's Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a competitively-bid delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of LONSURF (TAS-102) 15 mg-6.14 mg tablets in quantities of 20 units. This is a firm fixed price delivery order with a ceiling value of $5,078.30 and an ultimate completion date of September 23, 2025. The contract is performed at the company's corporate office location in Conshohocken, Pennsylvania. This award carries no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $10,173.33 to AmerisourceBergen Drug Corp for the supply of Lonsurf (20 mg-8.19 mg tablets, quantity 60) under a firm fixed price contract type. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive procurement. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support...
- This federal contract award is a $10,173.33 Firm Fixed Price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LONSURF 20 MG-8.19 MG Tablet 60S, a pharmaceutical product, with a completion date of June 13, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LONSURF 20 MG-8.19 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $12,712.48 and a period of performance ending on July 23, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. AmerisourceBergen Drug Corp...
- This is a $7,685.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 15 MG-6.14 MG tablets, which are used for medical treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
- The Defense Logistics Agency awarded a $6,760.14 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Lonsurf (20 mg-8.19 mg tablets) in quantities of 40 units. This is a firm fixed price contract with an ultimate completion date of August 12, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAHYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LONSURF (TAS-102) 20 mg-8.19 mg tablets in a quantity of 40 units, valued at $6,760.14 under a firm fixed price contract. This award, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, carries no set-aside designation and represents a competitive delivery order. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LONSURF is a prescription chemotherapy medication used in the treatment of colorectal and gastric cancers, reflecting the Defense Logistics Agency's pharmaceutical supply mission to support military healthcare operations. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen's extensive contract portfolio with the Defense Logistics Agency encompasses a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities supporting military and veteran healthcare systems globally. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet federal medical procurement requirements across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 9/10/25 |